Sa1108 Cost-Effectiveness of Golimumab Versus Infliximab and Adalimumab for the Treatment of Moderate to Severe Ulcerative Colitis
Autor*in: |
Thorlund, Kristian [verfasserIn] |
---|
Format: |
E-Artikel |
---|
Erschienen: |
2014 |
---|
Übergeordnetes Werk: |
Enthalten in: Ubiquitin protease Ubp8 is necessary for - Leo, Manuela ELSEVIER, 2018, official publication of the American Gastroenterological Association, Stanford, Calif |
---|---|
Übergeordnetes Werk: |
volume:146 ; year:2014 ; number:5 ; pages:0 |
Links: |
---|
DOI / URN: |
10.1016/S0016-5085(14)60712-5 |
---|
Katalog-ID: |
ELV012615226 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV012615226 | ||
003 | DE-627 | ||
005 | 20230623101021.0 | ||
007 | cr uuu---uuuuu | ||
008 | 180602s2014 xx |||||o 00| ||und c | ||
024 | 7 | |a 10.1016/S0016-5085(14)60712-5 |2 doi | |
028 | 5 | 2 | |a GBVA2014021000027.pica |
035 | |a (DE-627)ELV012615226 | ||
035 | |a (ELSEVIER)S0016-5085(14)60712-5 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
082 | 0 | |a 610 | |
082 | 0 | 4 | |a 610 |q DE-600 |
082 | 0 | 4 | |a 570 |q VZ |
084 | |a BIODIV |q DE-30 |2 fid | ||
084 | |a 35.70 |2 bkl | ||
084 | |a 42.12 |2 bkl | ||
084 | |a 42.15 |2 bkl | ||
100 | 1 | |a Thorlund, Kristian |e verfasserin |4 aut | |
245 | 1 | 0 | |a Sa1108 Cost-Effectiveness of Golimumab Versus Infliximab and Adalimumab for the Treatment of Moderate to Severe Ulcerative Colitis |
264 | 1 | |c 2014 | |
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
700 | 1 | |a Druyts, Eric |4 oth | |
700 | 1 | |a Kanters, Steve |4 oth | |
700 | 1 | |a Eapen, Shawn |4 oth | |
700 | 1 | |a Mills, Edward |4 oth | |
773 | 0 | 8 | |i Enthalten in |n HighWire Press |a Leo, Manuela ELSEVIER |t Ubiquitin protease Ubp8 is necessary for |d 2018 |d official publication of the American Gastroenterological Association |g Stanford, Calif |w (DE-627)ELV000307017 |
773 | 1 | 8 | |g volume:146 |g year:2014 |g number:5 |g pages:0 |
856 | 4 | 0 | |u https://doi.org/10.1016/S0016-5085(14)60712-5 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
912 | |a FID-BIODIV | ||
912 | |a SSG-OLC-PHA | ||
936 | b | k | |a 35.70 |j Biochemie: Allgemeines |q VZ |
936 | b | k | |a 42.12 |j Biophysik |q VZ |
936 | b | k | |a 42.15 |j Zellbiologie |q VZ |
951 | |a AR | ||
952 | |d 146 |j 2014 |e 5 |h 0 |y 146.2014, 5, S-202- | ||
953 | |2 045F |a 610 |
author_variant |
k t kt |
---|---|
matchkey_str |
thorlundkristiandruytserickanterssteveea:2014----:a18otfetvnsoglmmbessnlxmbnaaiuafrhtetetfoe |
hierarchy_sort_str |
2014 |
bklnumber |
35.70 42.12 42.15 |
publishDate |
2014 |
allfields |
10.1016/S0016-5085(14)60712-5 doi GBVA2014021000027.pica (DE-627)ELV012615226 (ELSEVIER)S0016-5085(14)60712-5 DE-627 ger DE-627 rakwb 610 610 DE-600 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl 42.15 bkl Thorlund, Kristian verfasserin aut Sa1108 Cost-Effectiveness of Golimumab Versus Infliximab and Adalimumab for the Treatment of Moderate to Severe Ulcerative Colitis 2014 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Druyts, Eric oth Kanters, Steve oth Eapen, Shawn oth Mills, Edward oth Enthalten in HighWire Press Leo, Manuela ELSEVIER Ubiquitin protease Ubp8 is necessary for 2018 official publication of the American Gastroenterological Association Stanford, Calif (DE-627)ELV000307017 volume:146 year:2014 number:5 pages:0 https://doi.org/10.1016/S0016-5085(14)60712-5 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA 35.70 Biochemie: Allgemeines VZ 42.12 Biophysik VZ 42.15 Zellbiologie VZ AR 146 2014 5 0 146.2014, 5, S-202- 045F 610 |
spelling |
10.1016/S0016-5085(14)60712-5 doi GBVA2014021000027.pica (DE-627)ELV012615226 (ELSEVIER)S0016-5085(14)60712-5 DE-627 ger DE-627 rakwb 610 610 DE-600 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl 42.15 bkl Thorlund, Kristian verfasserin aut Sa1108 Cost-Effectiveness of Golimumab Versus Infliximab and Adalimumab for the Treatment of Moderate to Severe Ulcerative Colitis 2014 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Druyts, Eric oth Kanters, Steve oth Eapen, Shawn oth Mills, Edward oth Enthalten in HighWire Press Leo, Manuela ELSEVIER Ubiquitin protease Ubp8 is necessary for 2018 official publication of the American Gastroenterological Association Stanford, Calif (DE-627)ELV000307017 volume:146 year:2014 number:5 pages:0 https://doi.org/10.1016/S0016-5085(14)60712-5 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA 35.70 Biochemie: Allgemeines VZ 42.12 Biophysik VZ 42.15 Zellbiologie VZ AR 146 2014 5 0 146.2014, 5, S-202- 045F 610 |
allfields_unstemmed |
10.1016/S0016-5085(14)60712-5 doi GBVA2014021000027.pica (DE-627)ELV012615226 (ELSEVIER)S0016-5085(14)60712-5 DE-627 ger DE-627 rakwb 610 610 DE-600 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl 42.15 bkl Thorlund, Kristian verfasserin aut Sa1108 Cost-Effectiveness of Golimumab Versus Infliximab and Adalimumab for the Treatment of Moderate to Severe Ulcerative Colitis 2014 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Druyts, Eric oth Kanters, Steve oth Eapen, Shawn oth Mills, Edward oth Enthalten in HighWire Press Leo, Manuela ELSEVIER Ubiquitin protease Ubp8 is necessary for 2018 official publication of the American Gastroenterological Association Stanford, Calif (DE-627)ELV000307017 volume:146 year:2014 number:5 pages:0 https://doi.org/10.1016/S0016-5085(14)60712-5 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA 35.70 Biochemie: Allgemeines VZ 42.12 Biophysik VZ 42.15 Zellbiologie VZ AR 146 2014 5 0 146.2014, 5, S-202- 045F 610 |
allfieldsGer |
10.1016/S0016-5085(14)60712-5 doi GBVA2014021000027.pica (DE-627)ELV012615226 (ELSEVIER)S0016-5085(14)60712-5 DE-627 ger DE-627 rakwb 610 610 DE-600 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl 42.15 bkl Thorlund, Kristian verfasserin aut Sa1108 Cost-Effectiveness of Golimumab Versus Infliximab and Adalimumab for the Treatment of Moderate to Severe Ulcerative Colitis 2014 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Druyts, Eric oth Kanters, Steve oth Eapen, Shawn oth Mills, Edward oth Enthalten in HighWire Press Leo, Manuela ELSEVIER Ubiquitin protease Ubp8 is necessary for 2018 official publication of the American Gastroenterological Association Stanford, Calif (DE-627)ELV000307017 volume:146 year:2014 number:5 pages:0 https://doi.org/10.1016/S0016-5085(14)60712-5 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA 35.70 Biochemie: Allgemeines VZ 42.12 Biophysik VZ 42.15 Zellbiologie VZ AR 146 2014 5 0 146.2014, 5, S-202- 045F 610 |
allfieldsSound |
10.1016/S0016-5085(14)60712-5 doi GBVA2014021000027.pica (DE-627)ELV012615226 (ELSEVIER)S0016-5085(14)60712-5 DE-627 ger DE-627 rakwb 610 610 DE-600 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl 42.15 bkl Thorlund, Kristian verfasserin aut Sa1108 Cost-Effectiveness of Golimumab Versus Infliximab and Adalimumab for the Treatment of Moderate to Severe Ulcerative Colitis 2014 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Druyts, Eric oth Kanters, Steve oth Eapen, Shawn oth Mills, Edward oth Enthalten in HighWire Press Leo, Manuela ELSEVIER Ubiquitin protease Ubp8 is necessary for 2018 official publication of the American Gastroenterological Association Stanford, Calif (DE-627)ELV000307017 volume:146 year:2014 number:5 pages:0 https://doi.org/10.1016/S0016-5085(14)60712-5 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA 35.70 Biochemie: Allgemeines VZ 42.12 Biophysik VZ 42.15 Zellbiologie VZ AR 146 2014 5 0 146.2014, 5, S-202- 045F 610 |
source |
Enthalten in Ubiquitin protease Ubp8 is necessary for Stanford, Calif volume:146 year:2014 number:5 pages:0 |
sourceStr |
Enthalten in Ubiquitin protease Ubp8 is necessary for Stanford, Calif volume:146 year:2014 number:5 pages:0 |
format_phy_str_mv |
Article |
bklname |
Biochemie: Allgemeines Biophysik Zellbiologie |
institution |
findex.gbv.de |
dewey-raw |
610 |
isfreeaccess_bool |
false |
container_title |
Ubiquitin protease Ubp8 is necessary for |
authorswithroles_txt_mv |
Thorlund, Kristian @@aut@@ Druyts, Eric @@oth@@ Kanters, Steve @@oth@@ Eapen, Shawn @@oth@@ Mills, Edward @@oth@@ |
publishDateDaySort_date |
2014-01-01T00:00:00Z |
hierarchy_top_id |
ELV000307017 |
dewey-sort |
3610 |
id |
ELV012615226 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV012615226</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623101021.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2014 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S0016-5085(14)60712-5</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014021000027.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV012615226</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0016-5085(14)60712-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIODIV</subfield><subfield code="q">DE-30</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.70</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">42.12</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">42.15</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Thorlund, Kristian</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Sa1108 Cost-Effectiveness of Golimumab Versus Infliximab and Adalimumab for the Treatment of Moderate to Severe Ulcerative Colitis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Druyts, Eric</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kanters, Steve</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Eapen, Shawn</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mills, Edward</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">HighWire Press</subfield><subfield code="a">Leo, Manuela ELSEVIER</subfield><subfield code="t">Ubiquitin protease Ubp8 is necessary for</subfield><subfield code="d">2018</subfield><subfield code="d">official publication of the American Gastroenterological Association</subfield><subfield code="g">Stanford, Calif</subfield><subfield code="w">(DE-627)ELV000307017</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:146</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:5</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S0016-5085(14)60712-5</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-BIODIV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.70</subfield><subfield code="j">Biochemie: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">42.12</subfield><subfield code="j">Biophysik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">42.15</subfield><subfield code="j">Zellbiologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">146</subfield><subfield code="j">2014</subfield><subfield code="e">5</subfield><subfield code="h">0</subfield><subfield code="y">146.2014, 5, S-202-</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
author |
Thorlund, Kristian |
spellingShingle |
Thorlund, Kristian ddc 610 ddc 570 fid BIODIV bkl 35.70 bkl 42.12 bkl 42.15 Sa1108 Cost-Effectiveness of Golimumab Versus Infliximab and Adalimumab for the Treatment of Moderate to Severe Ulcerative Colitis |
authorStr |
Thorlund, Kristian |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV000307017 |
format |
electronic Article |
dewey-ones |
610 - Medicine & health 570 - Life sciences; biology |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
610 610 DE-600 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl 42.15 bkl Sa1108 Cost-Effectiveness of Golimumab Versus Infliximab and Adalimumab for the Treatment of Moderate to Severe Ulcerative Colitis |
topic |
ddc 610 ddc 570 fid BIODIV bkl 35.70 bkl 42.12 bkl 42.15 |
topic_unstemmed |
ddc 610 ddc 570 fid BIODIV bkl 35.70 bkl 42.12 bkl 42.15 |
topic_browse |
ddc 610 ddc 570 fid BIODIV bkl 35.70 bkl 42.12 bkl 42.15 |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
e d ed s k sk s e se e m em |
hierarchy_parent_title |
Ubiquitin protease Ubp8 is necessary for |
hierarchy_parent_id |
ELV000307017 |
dewey-tens |
610 - Medicine & health 570 - Life sciences; biology |
hierarchy_top_title |
Ubiquitin protease Ubp8 is necessary for |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV000307017 |
title |
Sa1108 Cost-Effectiveness of Golimumab Versus Infliximab and Adalimumab for the Treatment of Moderate to Severe Ulcerative Colitis |
ctrlnum |
(DE-627)ELV012615226 (ELSEVIER)S0016-5085(14)60712-5 |
title_full |
Sa1108 Cost-Effectiveness of Golimumab Versus Infliximab and Adalimumab for the Treatment of Moderate to Severe Ulcerative Colitis |
author_sort |
Thorlund, Kristian |
journal |
Ubiquitin protease Ubp8 is necessary for |
journalStr |
Ubiquitin protease Ubp8 is necessary for |
isOA_bool |
false |
dewey-hundreds |
600 - Technology 500 - Science |
recordtype |
marc |
publishDateSort |
2014 |
contenttype_str_mv |
zzz |
container_start_page |
0 |
author_browse |
Thorlund, Kristian |
container_volume |
146 |
class |
610 610 DE-600 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl 42.15 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
Thorlund, Kristian |
doi_str_mv |
10.1016/S0016-5085(14)60712-5 |
dewey-full |
610 570 |
title_sort |
sa1108 cost-effectiveness of golimumab versus infliximab and adalimumab for the treatment of moderate to severe ulcerative colitis |
title_auth |
Sa1108 Cost-Effectiveness of Golimumab Versus Infliximab and Adalimumab for the Treatment of Moderate to Severe Ulcerative Colitis |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA |
container_issue |
5 |
title_short |
Sa1108 Cost-Effectiveness of Golimumab Versus Infliximab and Adalimumab for the Treatment of Moderate to Severe Ulcerative Colitis |
url |
https://doi.org/10.1016/S0016-5085(14)60712-5 |
remote_bool |
true |
author2 |
Druyts, Eric Kanters, Steve Eapen, Shawn Mills, Edward |
author2Str |
Druyts, Eric Kanters, Steve Eapen, Shawn Mills, Edward |
ppnlink |
ELV000307017 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth oth |
doi_str |
10.1016/S0016-5085(14)60712-5 |
up_date |
2024-07-06T16:46:51.827Z |
_version_ |
1803848947415908352 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV012615226</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623101021.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2014 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S0016-5085(14)60712-5</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014021000027.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV012615226</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0016-5085(14)60712-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIODIV</subfield><subfield code="q">DE-30</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.70</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">42.12</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">42.15</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Thorlund, Kristian</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Sa1108 Cost-Effectiveness of Golimumab Versus Infliximab and Adalimumab for the Treatment of Moderate to Severe Ulcerative Colitis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Druyts, Eric</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kanters, Steve</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Eapen, Shawn</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mills, Edward</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">HighWire Press</subfield><subfield code="a">Leo, Manuela ELSEVIER</subfield><subfield code="t">Ubiquitin protease Ubp8 is necessary for</subfield><subfield code="d">2018</subfield><subfield code="d">official publication of the American Gastroenterological Association</subfield><subfield code="g">Stanford, Calif</subfield><subfield code="w">(DE-627)ELV000307017</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:146</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:5</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S0016-5085(14)60712-5</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-BIODIV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.70</subfield><subfield code="j">Biochemie: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">42.12</subfield><subfield code="j">Biophysik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">42.15</subfield><subfield code="j">Zellbiologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">146</subfield><subfield code="j">2014</subfield><subfield code="e">5</subfield><subfield code="h">0</subfield><subfield code="y">146.2014, 5, S-202-</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
score |
7.400118 |